<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wieland L</submitter><funding>European Regional Development Fund under the local program “Sachsen-Anhalt WISSENSCHAFT Schwerpunkte”</funding><pagination>3619</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9688211</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(22)</volume><pubmed_abstract>The immune pathogenesis of multiple sclerosis (MS) is thought to be triggered by environmental factors in individuals with an unfavorable genetic predisposition. Epstein-Barr virus (EBV) infection is a major risk factor for subsequent development of MS. Human endogenous retroviruses (HERVs) can be activated by EBV, and might be a missing link between an initial EBV infection and the later onset of MS. In this study, we investigated differential gene expression patterns in EBV-immortalized lymphoblastoid B cell lines (LCL) from MS-affected individuals (MSLCL) and controls by using RNAseq and qRT-PCR. RNAseq data from LCL mapped to the human genome and a virtual virus metagenome were used to identify possible biomarkers for MS or disease-relevant risk factors, e.g., the relapse rate. We observed that lytic EBNA-1 transcripts seemed to be negatively correlated with age leading to an increased expression in LCL from younger PBMC donors. Further, HERV-K (HML-2) GAG was increased upon EBV-triggered immortalization. Besides the well-known transactivation of HERV-K18, our results suggest that another six HERV loci are up-regulated upon stimulation with EBV. We identified differentially expressed genes in MSLCL, e.g., several HERV-K loci, ERVMER61-1 and ERV3-1, as well as genes associated with relapses. In summary, EBV induces genes and HERV in LCL that might be suitable as biomarkers for MS or the relapse risk.</pubmed_abstract><journal>Cells</journal><pubmed_title>Epstein-Barr Virus-Induced Genes and Endogenous Retroviruses in Immortalized B Cells from Patients with Multiple Sclerosis.</pubmed_title><pmcid>PMC9688211</pmcid><funding_grant_id>ZS/2018/12/96228</funding_grant_id><pubmed_authors>Wieland L</pubmed_authors><pubmed_authors>Tarabuko A</pubmed_authors><pubmed_authors>Hoffmann F</pubmed_authors><pubmed_authors>Kornhuber ME</pubmed_authors><pubmed_authors>Schwarz T</pubmed_authors><pubmed_authors>Kruger A</pubmed_authors><pubmed_authors>Junghans J</pubmed_authors><pubmed_authors>Staege MS</pubmed_authors><pubmed_authors>Volkmer I</pubmed_authors><pubmed_authors>Engel K</pubmed_authors><pubmed_authors>Emmer A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epstein-Barr Virus-Induced Genes and Endogenous Retroviruses in Immortalized B Cells from Patients with Multiple Sclerosis.</name><description>The immune pathogenesis of multiple sclerosis (MS) is thought to be triggered by environmental factors in individuals with an unfavorable genetic predisposition. Epstein-Barr virus (EBV) infection is a major risk factor for subsequent development of MS. Human endogenous retroviruses (HERVs) can be activated by EBV, and might be a missing link between an initial EBV infection and the later onset of MS. In this study, we investigated differential gene expression patterns in EBV-immortalized lymphoblastoid B cell lines (LCL) from MS-affected individuals (MSLCL) and controls by using RNAseq and qRT-PCR. RNAseq data from LCL mapped to the human genome and a virtual virus metagenome were used to identify possible biomarkers for MS or disease-relevant risk factors, e.g., the relapse rate. We observed that lytic EBNA-1 transcripts seemed to be negatively correlated with age leading to an increased expression in LCL from younger PBMC donors. Further, HERV-K (HML-2) GAG was increased upon EBV-triggered immortalization. Besides the well-known transactivation of HERV-K18, our results suggest that another six HERV loci are up-regulated upon stimulation with EBV. We identified differentially expressed genes in MSLCL, e.g., several HERV-K loci, ERVMER61-1 and ERV3-1, as well as genes associated with relapses. In summary, EBV induces genes and HERV in LCL that might be suitable as biomarkers for MS or the relapse risk.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2024-11-10T03:40:53.848Z</modification><creation>2024-11-10T03:40:53.848Z</creation></dates><accession>S-EPMC9688211</accession><cross_references><pubmed>36429047</pubmed><doi>10.3390/cells11223619</doi></cross_references></HashMap>